The purpose of this study is to compare two healthy diets (according to official Spanish guidelines) that have been shown to be effective in the treatment of type 2 diabetes in order to see if one is better than the other. Another goal is to test the hypothesis that food choice has metabolic effects that are independent of macro/micronutrient composition, fiber content, glycemic load and weight loss in the treatment of type 2 diabetes.
There is some uncertainty with respect to the optimal dietary treatment of type 2 diabetes. In addition to energy balance, macronutrient composition, dietary fiber and glycemic load, increasing evidence suggests that the direct endocrine effects of food may be important. In this trial, the intervention is based on two diets. The healthy diet with grains and dairy is based on whole grains, low-fat dairy, fish, shellfish, fruit, vegetables, legumes, eggs, nuts and refined vegetable oils rich in monounsaturated fatty acids (this is called "healthy diet A"). The healthy diet without grains and dairy is based on fish, shellfish, lean meat, fruit, vegetables, root vegetables, eggs and nuts, but excludes grains, legumes, refined vegetable oils, dairy products and salt (this is called "healthy diet B"). Both diets were classified as very healthy using validated nutritional software, and are considered healthy regarding macronutrient composition, fiber, mineral and vitamin intake according to the official Spanish dietary guidelines. The macro and micronutrient ratios, fiber content and glycemic load in healthy diet A and healthy diet B have been set to be equal. The goal is to include 15 patients (\>18 years) with medical diagnosis of type 2 diabetes, with or without medication, and increased waist circumference (≥80 cm for women and ≥94 cm for men), to a cross-over trial during two periods of 4-weeks separated by a 6-week washout period. Lunch will be served in a hospital kitchen for control of nutrient intake, while the rest of meals will be eaten at home according to specific directions. The working hypothesis of this study is that food choice has beneficial effects on the control of glucose beyond macro/micronutrient composition, fiber content, glycemic load and weight loss. This study will provide information on whether food choice and diet quality has greater impact than macro/micronutrient composition, fiber content, glycemic load and weight loss in glucose control in patients with type 2 diabetes, and the need to conduct a long-term trial testing our hypothesis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
14
Healthy diet A will include fruit, vegetables, fish, shellfish, lean meat, nuts, eggs and olive oil. Macro/micronutrient composition, fiber intake and glycemic load will not differ from healthy diet B. Healthy diet A will include substantial amounts of whole grains, low-fat dairy and legumes (this is called "healthy diet with grains and dairy"). This diet is classified as very healthy using validated nutritional software. It is in accordance with official Spanish dietary recommendations for people with diabetes type 2 regarding macronutrient composition, dietary fiber, minerals and vitamins.
Healthy diet B will include fruit, vegetables, fish, shellfish, lean meat, nuts, eggs and olive oil. Macro/micronutrient composition, fiber intake and glycemic load will not differ from healthy diet A. Healthy diet B will exclude grains, legumes and dairy, which will largely be replaced by root vegetables, vegetables and fruit, and slightly more lean meat, fish and nuts (this is called "healthy diet without grains and dairy"). Salt intake will be lower in healthy diet B. This diet is classified as very healthy using validated nutritional software. It is in accordance with official Spanish dietary recommendations for people with diabetes type 2 regarding macronutrient composition, dietary fiber, minerals and vitamins.
Hospital Insular de Lanzarote
Arrecife, Las Palmas, Spain
Fasting fructosamine
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Fasting glucagon
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Area under the curve for glucose (AUC glucose0-120) at the oral glucose tolerance test
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Area under the curve for glucagon (AUC glucagon0-120) at the oral glucose tolerance test
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Fasting plasma glucose
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Total cholesterol
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Low-density lipoprotein (LDL) cholesterol
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
High-density lipoprotein (HDL) cholesterol
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Triglycerides
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Systolic and diastolic blood pressure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
High-sensitive C-reactive protein
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Waist circumference
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Hip circumference
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Sagittal abdominal diameter
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Tricipital, bicipital, suprailiac and subscapular skinfold thickness
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Satiation measured on a likert scale at food intake during 4 consecutive days
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Quality of life using a validated spanish version of the SF-36 questionnaire
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Change in medication
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Body weight
Time frame: To be assessed at baseline and after 4, 10 and 14 weeks
Fasting HbA1c
Time frame: Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks